Alzamend Neuro director Andrew H. Woo, M.D., Ph.D. passed away on Nov. 14, 2025

Alzamend Neuro, Inc.

Andrew H. Woo served as a director since the company's IPO in June 2021.
William B. Horne, Chairman, expressed condolences; Woo is succeeded by no replacement yet.
No other material events reported; financial statements not affected.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.